Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects
Lindsey Anderson, Jamie M. Tamayose, José M. Garcia
Molecular and Cellular Endocrinology (2017) Vol. 464, pp. 65-74
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Growth Hormone Deficiency in Adults and Patients Transitioning from Pediatric to Adult Care
Kevin C.J. Yuen, Beverly M. K. Biller, Sally Radovick, et al.
Endocrine Practice (2019) Vol. 25, Iss. 11, pp. 1191-1232
Open Access | Times Cited: 215
Recreational and ergogenic substance use and substance use disorders in elite athletes: a narrative review
David McDuff, Todd Stull, João Maurício Castaldelli-Maia, et al.
British Journal of Sports Medicine (2019) Vol. 53, Iss. 12, pp. 754-760
Closed Access | Times Cited: 91
Anything but androgens: How image and performance enhancing drug consumers manage body composition and health through off-label use of medicines
Timothy Piatkowski, Kim Akrigg, Luke Cox, et al.
Performance Enhancement & Health (2025), pp. 100329-100329
Open Access | Times Cited: 1
Analytical Approaches in Human Sports Drug Testing: Recent Advances, Challenges, and Solutions
Mario Thevis, Katja Walpurgis, Andreas Thomas
Analytical Chemistry (2019) Vol. 92, Iss. 1, pp. 506-523
Closed Access | Times Cited: 49
Treatments for people who use anabolic androgenic steroids: a scoping review
Geoff Bates, Marie Claire Van Hout, Joseph Tay Wee Teck, et al.
Harm Reduction Journal (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 43
If you find me on the floor, stick some sugar in my mouth : The social production (and protection) of insulin risk among IPED communities
Kim Akrigg, Luke Cox, Luke A. Turnock, et al.
Drugs Education Prevention and Policy (2025), pp. 1-12
Open Access
Endogenous Repair and Regeneration of Injured Articular Cartilage: A Challenging but Promising Therapeutic Strategy
Hongzhi Hu, Weijian Liu, Caixia Sun, et al.
Aging and Disease (2021) Vol. 12, Iss. 3, pp. 886-886
Open Access | Times Cited: 32
On the Relentless Pursuit of an Oral Insulin Delivery System: How Far is Too Far?
Sourav Bhattacharjee
Advanced Therapeutics (2025)
Open Access
Falsification of biotechnology drugs: current dangers and/or future disasters?
Steven Janvier, Bart De Spiegeleer, Céline Vanhee, et al.
Journal of Pharmaceutical and Biomedical Analysis (2018) Vol. 161, pp. 175-191
Closed Access | Times Cited: 34
Sports pharmacology: A medical pharmacologist’s perspective
Harshad Malve
Journal of Pharmacy And Bioallied Sciences (2018) Vol. 10, Iss. 3, pp. 126-126
Open Access | Times Cited: 28
Off-Label Use and Misuse of Testosterone, Growth Hormone, Thyroid Hormone, and Adrenal Supplements: Risks and Costs of a Growing Problem
Michael S. Irwig, Maria Fleseriu, Jacqueline Jonklaas, et al.
Endocrine Practice (2020) Vol. 26, Iss. 3, pp. 340-353
Closed Access | Times Cited: 25
Performance‐enhancing drugs and the Olympics
C. James Watson, Genevra L. Stone, Daniel L. Overbeek, et al.
Journal of Internal Medicine (2022) Vol. 291, Iss. 2, pp. 181-196
Closed Access | Times Cited: 15
The Other Face of Insulin—Overdose and Its Effects
Szymon Rzepczyk, Klaudia Dolińska-Kaczmarek, Aleksandra Uruska, et al.
Toxics (2022) Vol. 10, Iss. 3, pp. 123-123
Open Access | Times Cited: 15
IGF-1 as a Potential Therapy for Spinocerebellar Ataxia Type 3
Yong-Shiou Lin, Wen‐Ling Cheng, Jui‐Chih Chang, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 505-505
Open Access | Times Cited: 14
Development and validation of a method for quantification of human insulin and its synthetic analogues in plasma and post-mortem sera by LC-MS/HRMS
Charline Bottinelli, Raul Nicoli, Fabien Bévalot, et al.
Talanta (2020) Vol. 225, pp. 122047-122047
Closed Access | Times Cited: 21
Early detection and assessment of intensive care unit-acquired weakness: a comprehensive review
HANAN ELKALAWY, Pavan Sekhar, Wael Abosena
Acute and Critical Care (2023) Vol. 38, Iss. 4, pp. 409-424
Open Access | Times Cited: 7
Social Interest Data as a Proxy for Off-Label Performance-Enhancing Drug Use: Implications and Clinical Considerations
Philip A Holubeck, Andrew C Eksi, Kyle Gillett, et al.
Cureus (2024)
Open Access | Times Cited: 2
Interpol review of controlled substances 2016–2019
Nicole S. Jones, Jeffrey H. Comparin
Forensic Science International Synergy (2020) Vol. 2, pp. 608-669
Open Access | Times Cited: 18
Emerging Treatment Options for Sarcopenia in Chronic Liver Disease
Yun Kim
Life (2021) Vol. 11, Iss. 3, pp. 250-250
Open Access | Times Cited: 17
GH/IGF-1 Abnormalities and Muscle Impairment: From Basic Research to Clinical Practice
Betina Biagetti, Rafael Simó
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 1, pp. 415-415
Open Access | Times Cited: 15
Synthetic Peptides in Doping Control: A Powerful Tool for an Analytical Challenge
Néstor Alejandro Gómez-Guerrero, Nicolás Mateo González‐López, Juan Diego Zapata-Velásquez, et al.
ACS Omega (2022) Vol. 7, Iss. 43, pp. 38193-38206
Open Access | Times Cited: 10
A high-throughput assay for the quantification of intact Insulin-like Growth Factor I in human serum using online SPE-LC-HRMS
Gilles Coppieters, Péter Judák, Nicolas Van Haecke, et al.
Clinica Chimica Acta (2020) Vol. 510, pp. 391-399
Open Access | Times Cited: 15
Annual banned‐substance review: Analytical approaches in human sports drug testing
Mario Thevis, Tiia Kuuranne, Hans Geyer
Drug Testing and Analysis (2018) Vol. 11, Iss. 1, pp. 8-26
Open Access | Times Cited: 15
Impurity profiling of the most frequently encountered falsified polypeptide drugs on the Belgian market
Steven Janvier, Karlien Cheyns, Michaël Canfyn, et al.
Talanta (2018) Vol. 188, pp. 795-807
Closed Access | Times Cited: 14
PTH and PTHrP Actions on Bone
Larry J. Suva, Peter A. Friedman
Handbook of experimental pharmacology (2020), pp. 27-45
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top